Literature DB >> 16110124

Pancreatic endocrine neoplasm can mimic serous cystadenoma.

Hiroshi Imaoka1, Kenji Yamao, Ahmed A S Salem, Akira Sawaki, Kuniyuki Takahashi, Nobumasa Mizuno, Hiroki Kawai, Masahiro Tajika, Toshifumi Isaka, Yasuyuki Okamoto, Yasuhiro Shimizu, Akio Yanagisawa.   

Abstract

A 57-yr-old female patient was referred to our hospital with a cystic lesion of the head of the pancreas that had been noted on abdominal computed tomography (CT). Endoscopic ultrasonography (EUS) showed a 3.0 cm rounded mass in the head of the pancreas. EUS images showed that the tumor had a solid component consisting of multiple microcysts separated by septae and a cystic component consisting of a macrocystic lesion. Thus, the tumor was suspected of being a serous cystadenoma (SCA). However, the histopathological diagnosis based on endoscopic ultrasound- guided fine-needle-aspiration biopsy (EUS-FNAB) was that of a pancreatic endocrine neoplasm (PEN). Surgical resection was performed. Despite having very similar macroscopic findings to SCA, microscopic examination revealed that the patient's tumor was definitely a PEN. This case suggests that it is very difficult to distinguish PENs from SCAs based solely on imaging methods. EUS-FNAB is essential for determining the appropriate therapeutic strategy, as it provides the histopathological diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16110124     DOI: 10.1385/IJGC:35:3:217

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  15 in total

1.  Serous cystadenocarcinoma of the pancreas: a new entity?

Authors:  D H George; F Murphy; R Michalski; B G Ulmer
Journal:  Am J Surg Pathol       Date:  1989-01       Impact factor: 6.394

2.  Cystic tumors of the pancreas: preoperative imaging, diagnosis, and treatment.

Authors:  Demitrios Kehagias; Vassilios Smyrniotis; Angelos Kalovidouris; Athanassios Gouliamos; Elias Kostopanagiotou; John Vassiliou; Lambros Vlahos
Journal:  Int Surg       Date:  2002 Jul-Sep

3.  Diagnostic dilemmas in patients with cystic neoplasms of the pancreas.

Authors:  R H Turnage; F E Eckhauser; A I Vinik; W E Strodel; N W Thompson; A Smid; D Smid
Journal:  Int J Pancreatol       Date:  1988-12

4.  Cystic pancreatic neoplasms: computed tomography and magnetic resonance imaging findings.

Authors:  D Kehagias; V Smyrniotis; A Gouliamos; L Vlahos
Journal:  Int J Pancreatol       Date:  2000-12

5.  Nonfunctioning malignant neuroendocrine tumors of the pancreas.

Authors:  F E Eckhauser; P S Cheung; A I Vinik; W E Strodel; R V Lloyd; N W Thompson
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

6.  Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients.

Authors:  B Eriksson; K Oberg; B Skogseid
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

7.  Utility of EUS in the evaluation of cystic pancreatic lesions.

Authors:  Robert Sedlack; Aboud Affi; Enrique Vazquez-Sequeiros; Ian D Norton; Jonathan E Clain; Maurits J Wiersema
Journal:  Gastrointest Endosc       Date:  2002-10       Impact factor: 9.427

8.  Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences.

Authors:  M Siech; K Tripp; B Schmidt-Rohlfing; T Mattfeldt; U Widmaier; F Gansauge; J Görich; H G Beger
Journal:  Langenbecks Arch Surg       Date:  1998-03       Impact factor: 3.445

9.  Cystic neuroendocrine neoplasms of the pancreas and liver.

Authors:  N W Thompson; F E Eckhauser; A I Vinik; R V Lloyd; R G Fiddian-Green; W E Strodel
Journal:  Ann Surg       Date:  1984-02       Impact factor: 12.969

Review 10.  Serous cystadenoma of the pancreas with invasive growth: benign or malignant?

Authors:  H Abe; K Kubota; M Mori; K Miki; M Minagawa; T Noie; W Kimura; M Makuuchi
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

View more
  1 in total

Review 1.  Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.

Authors:  James J Farrell
Journal:  Gut Liver       Date:  2015-09-23       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.